ArticleJournal of medical systems2025
Development of an Artificial Intelligence-Enabled Electrocardiography to Detect 23 Cardiac Arrhythmias and Predict Cardiovascular Outcomes.
Article in Journal of medical systems, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diagnostic Accuracy of Artificial Intelligence for Arrhythmia Detection Using the 12-Lead Electrocardiogram: A Systematic Review and Meta-Analysis.medRxiv : the preprint server for health sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Arrhythmias are common and can affect individuals with or without structural heart disease. Deep learning models (DLMs) have shown the ability to recognize arrhythmias using 12-lead electrocardiograms (ECGs). However, the limited types of arrhythmias and dataset robustness have hindered widespread adoption. This study aimed to develop a DLM capable of detecting various arrhythmias across diverse datasets. This algorithm development study utilized 22,130 ECGs, divided into development, tuning, validation, and competition sets. External validation was conducted on three open datasets (CODE-test, PTB-XL, CPSC2018) comprising 32,495 ECGs. The study also assessed the long-term risks of new-onset atrial fibrillation (AF), heart failure (HF), and mortality in individuals with false-positive AF detection by the DLM. In the validation set, the DLM achieved area under the receiver operating characteristic curve above 0.97 and sensitivity/specificity exceeding 90% across most arrhythmia classes. It demonstrated cardiologist-level performance, ranking first in balanced accuracy in a human-machine competition. External validation confirmed comparable performance. Individuals with false-positive AF detection had a significantly higher risk of new-onset AF (hazard ration [HR]: 1.69, 95% confidence interval [CI]: 1.11-2.59), HF (HR: 1.73, 95% CI: 1.20-2.51), and mortality (HR: 1.40, 95% CI: 1.02-1.92) compared to true-negative individuals after adjusting for age and sex. We developed an accurate DLM capable of detecting 23 cardiac arrhythmias across multiple datasets. This DLM serves as a valuable screening tool to aid physicians in identifying high-risk patients, with potential implications for early intervention and risk stratification.
Indexed as
Identifiers
40259136What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.